MARYAM NIAZI: Open Payments
NPI 1063706216 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 80 payments from 7 companies in 2025. Trend: 2023 $939 · 2024 $631 · 2025 $1,583
Food & beverage: $1,583
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 30 | $542 |
| ABBVIE INC. | 32 | $533 |
| Axsome Therapeutics, Inc. | 6 | $258 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $119 |
| Alkermes, Inc. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $37 |
Products named: COBENFY, VRAYLAR, Auvelity, CAPLYTA, ABILIFY MAINTENA, REXULTI, VIVITROL, ARISTADA.
Industry payments across OH — which companies pay providers there.
